| Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in … DM Lewinsohn, MK Leonard, PA LoBue, DL Cohn, CL Daley, E Desmond, ... Clinical Infectious Diseases 64 (2), e1-e33, 2017 | 1317 | 2017 |
| The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis A Somoskovi, LM Parsons, M Salfinger Respiratory research 2, 1-5, 2001 | 593 | 2001 |
| Characterization of rifampin-resistance in pathogenic mycobacteria DL Williams, C Waguespack, K Eisenach, JT Crawford, F Portaels, ... Antimicrobial agents and chemotherapy 38 (10), 2380-2386, 1994 | 476 | 1994 |
| Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin T Gumbo, A Louie, MR Deziel, W Liu, LM Parsons, M Salfinger, ... Antimicrobial agents and chemotherapy 51 (11), 3781-3788, 2007 | 424 | 2007 |
| Selection of a Moxifloxacin Dose That Suppresses Drug Resistance in Mycobacterium tuberculosis, by Use of an In Vitro Pharmacodynamic Infection Model and … T Gumbo, A Louie, MR Deziel, LM Parsons, M Salfinger, GL Drusano Journal of Infectious Diseases 190 (9), 1642-1651, 2004 | 406 | 2004 |
| Rapid and Simple Approach for Identification of Mycobacterium tuberculosis Complex Isolates by PCR-Based Genomic Deletion Analysis LM Parsons, R Brosch, ST Cole, A Somoskövi, A Loder, G Bretzel, ... Journal of clinical microbiology 40 (7), 2339-2345, 2002 | 379 | 2002 |
| Practical guidance for clinical microbiology laboratories: mycobacteria BA Forbes, GS Hall, MB Miller, SM Novak, MC Rowlinson, M Salfinger, ... Clinical microbiology reviews 31 (2), 10.1128/cmr. 00038-17, 2018 | 321 | 2018 |
| Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories JA Kiehlbauch, GE Hannett, M Salfinger, W Archinal, C Monserrat, ... Journal of clinical microbiology 38 (9), 3341-3348, 2000 | 298 | 2000 |
| Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis MH Larsen, C Vilchèze, L Kremer, GS Besra, L Parsons, M Salfinger, ... Molecular microbiology 46 (2), 453-466, 2002 | 291 | 2002 |
| Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens GE Pfyffer, P Kissling, EM Jahn, HM Welscher, M Salfinger, R Weber Journal of Clinical Microbiology 34 (4), 834-841, 1996 | 222 | 1996 |
| Multicenter Laboratory Validation of Susceptibility Testing of Mycobacterium tuberculosis against Classical Second-Line and Newer Antimicrobial Drugs by Using … GE Pfyffer, DA Bonato, A Ebrahimzadeh, W Gross, J Hotaling, J Kornblum, ... Journal of Clinical Microbiology 37 (10), 3179-3186, 1999 | 218 | 1999 |
| Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method M Salfinger, LB Heifets Antimicrobial agents and chemotherapy 32 (7), 1002-1004, 1988 | 209 | 1988 |
| Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis MD Cave, KD Eisenach, G Templeton, M Salfinger, G Mazurek, JH Bates, ... Journal of Clinical Microbiology 32 (1), 262-266, 1994 | 192 | 1994 |
| Diagnostic standards and classification of tuberculosis in adults and children NE Dunlap, J Bass, P Fujiwara, P Hopewell, CR Horsburgh, M Salfinger, ... American Journal of Respiratory and Critical Care Medicine 161 (4), 1376-1395, 2000 | 191 | 2000 |
| Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine: report of an outbreak and review of the literature JGH Gubler, M Salfinger, A von Graevenitz Chest 101 (5), 1245-1249, 1992 | 186 | 1992 |
| Molecular Characterization of Rifampin-Resistant Isolates of Mycobacterium tuberculosis from Hungary by DNA Sequencing and the Line Probe Assay Z Bártfai, A Somoskövi, C Ködmön, N Szabó, E Puskás, ... Journal of clinical microbiology 39 (10), 3736-3739, 2001 | 176 | 2001 |
| The new diagnostic mycobacteriology laboratory M Salfinger, GE Pfyffer European Journal of Clinical Microbiology and Infectious Diseases 13, 961-979, 1994 | 175 | 1994 |
| Lessons from a proficiency testing event for acid-fast microscopy Á Somoskövi, JE Hotaling, M Fitzgerald, D O’Donnell, LM Parsons, ... Chest 120 (1), 250-257, 2001 | 171 | 2001 |
| Laboratory diagnosis of mycobacterial infections: new tools and lessons learned LB Reller, MP Weinstein, YM Hale, GE Pfyffer, M Salfinger Clinical infectious diseases 33 (6), 834-846, 2001 | 153 | 2001 |
| Phenotypic and Molecular Characterization of Mycobacterium tuberculosis Isolates Resistant to both Isoniazid and Ethambutol LM Parsons, M Salfinger, A Clobridge, J Dormandy, L Mirabello, ... Antimicrobial agents and chemotherapy 49 (6), 2218-2225, 2005 | 130 | 2005 |
